LYST was recently established as a gene of interest in patients with acute myeloid leukemia (AML), colorectal cancer, epithelial ovarian cancer, multiple myeloma, pulmonary carcinosarcoma, and sporadic chordoma (33–39). This evidence concerns the gene LYST and AL amyloidosis.